Cell Reports Medicine
Издатель: Elsevier · ISSN 2666-3791 · 58 статей
- Transforming large language models into medical specialists via knowledge injection
- Retrieval-augmented generation in medicine: A scoping review of technical implementations, clinical applications, and ethical considerations
- From pelvis to brain: Clinical implications emerging from shared biology in endometriosis and migraine
- CNS targeted AAV gene therapies: Recent advances and clinical insights
- Safety and efficacy of high-current tTIS targeting left sgACC for major depressive disorder: A randomized, double-blind, sham-controlled trial
- Gut-derived glucagon-like peptides attenuate T cell-induced intestinal injury
- Isobavachalcone targets deubiquitinase OTUB1 to induce PD-L1 degradation and enhances antitumor immunity
- Lipid-engineered antibody-based therapeutics target inflamed joints and lymph nodes to enhance rheumatoid arthritis treatment
- Prognostic value of cfDNA methylation in locally advanced esophageal squamous cell cancer treated with neoadjuvant immunochemoradiotherapy
- Orally delivered metabolically reprogrammed probiotics for cascade-activated antitumor immunity in colorectal cancer
- Prediction of immunotherapy response using live tumor fragments from routine clinical biopsies
- Cell-free RNA signatures derived from the tumor microenvironment predict outcomes of CAR T therapy in large B cell lymphoma
- BT-115386, a MAT2A inhibitor, targets MTAP-deficient nasopharyngeal carcinoma via c-Myc and p53 modulation
- Reappraising muscarinic acetylcholine receptors as targets in substance use disorders
- Time-restricted feeding prevents acute liver injury by suppressing microbial anabolism of uric acid
- NKG2D overexpression potentiates CAR-T cells through costimulation by tumor NKG2D ligands
- Targeting oncogenic SOX2 condensates suppresses squamous cell carcinoma progression
- Targeting MMGT1 enhances immunotherapy efficacy in triple-negative breast cancer
- Inhibition of the CTP synthase 1 prevents GVHD and delays skin graft rejection revealing distinct alloreactive T cell responses
- A phase 2, open-label, single-arm clinical trial of the safety and efficacy of the JAK1/3 inhibitor tofacitinib in Down syndrome
- Allosteric modulation of YTHDFs by ellagic acid suppresses triple-negative breast cancer via non-canonical activation of the HIF-1α pathway
- L013 promotes NRF2 degradation in NRFA-subtype esophageal squamous cell carcinoma
- Functional O-specific polysaccharide-specific antibody responses in young children following Shigella infection in Bangladesh
- Structural basis for broad orthopoxvirus neutralization by two antibodies targeting distinct L1R epitopes
- Punicalin targets RSV glycoprotein and fusion protein at non-overlapping sites to prevent viral escape
- Potently neutralizing and protective human monoclonal antibodies against the measles fusion protein trimer
- Fusion-loop-engineered Zika mRNA vaccine elicits convergent B cell immunodominance to uncouple protection from ADE in macaques
- Potentiating immunotherapy in “immune-cold” solid tumors through orchestrating T cell immunity via tumor-specific genetic engineering
- Targeted lactate depletion via gluconeogenesis by engineered hepatocyte-based micronanorobots for radiosensitization and immune activation
- Tumor digital twins uncover therapeutic strategies in triple-negative breast cancer